8TZI
Human equilibrative nucleoside transporter-1, JH-ENT-01 bound
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | APS BEAMLINE 24-ID-C |
| Synchrotron site | APS |
| Beamline | 24-ID-C |
| Temperature [K] | 100 |
| Detector technology | CCD |
| Collection date | 2019-07-06 |
| Detector | ADSC QUANTUM 315 |
| Wavelength(s) | 0.9792 |
| Spacegroup name | P 32 2 1 |
| Unit cell lengths | 72.413, 72.413, 173.920 |
| Unit cell angles | 90.00, 90.00, 120.00 |
Refinement procedure
| Resolution | 58.990 - 2.700 |
| R-factor | 0.226 |
| Rwork | 0.229 |
| R-free | 0.25600 |
| Structure solution method | MOLECULAR REPLACEMENT |
| Starting model (for MR) | 6ob7 |
| RMSD bond length | 0.003 |
| RMSD bond angle | 0.544 |
| Data reduction software | XDS |
| Data scaling software | Aimless |
| Phasing software | PHENIX (1.20.1_4487) |
| Refinement software | PHENIX (1.20.1_4487) |
Data quality characteristics
| Overall | Outer shell | |
| Low resolution limit [Å] | 62.710 | 2.830 |
| High resolution limit [Å] | 2.700 | 2.700 |
| Number of reflections | 15151 | 1945 |
| <I/σ(I)> | 3.9 | |
| Completeness [%] | 99.8 | |
| Redundancy | 6.9 | |
| CC(1/2) | 0.970 | 0.328 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | LIPIDIC CUBIC PHASE | 9 | 298 | 35-50% PEG400, 0.1 M glycine, 0.5 M sodium chloride |






